FDA takes steps to enhance transparency of clinical trial data used in support of new drug approvals
Read more: FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs